MODERNA INC (NASDAQ: MRNA)

Overview
current price
$46.86
$46.86
change
0.00 | 0.00%
0.00 | 0.00%
Yesterday's Close
46.86
open
0.00
volume
0.07 M
30d. avg volume.
13.17 M
1 day
0.00 - 0.00
52 weeks
22.28 - 55.20
p/e
0.00
beta
1.1699
market cap
18.31 B
dividend yield
0.00%
Industry
-
News and Commentary
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax Moderna Inc. (MRNA&nbs...
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing S... The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr....
Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector Shares of Novavax Inc (NVAX
Market Update: S&P 500 Slips for Third Straight Session After Microsoft, Meta Platforms Earnings The broader market slipped from earlier highs on Thursday after tech giants Microsoft
Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles Moderna Inc. (MRNA&nbs...
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organization...
Moderna's mRNA Flu Vaccine Outperforms Standard Shots Moderna, Inc. (MRNA&nb...
CDC Reinstates 450 Workers After Layoffs Spark Public Health Concerns: Report The U.S. Centers for Disease Control and Prevention reversed course Wednesday, reinstating approximately 450 employees previously laid off under the Trump administration's federa...
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Pha... Novavax, Inc. (NVAX&nb...
StockTwits
StockTwits

Join now and unlock premium features